Concepedia
1
Publications
109
Citations
H-Index
2013
Active since
Affiliations
Eli Lilly (United States)(Current)
Henry Diaz is an author at Eli Lilly (United States) specializing in drug discovery, molecular pharmacology, and drug development.
Top concepts
MedicineBiochemistryPharmacologyDrug DiscoveryDrug DevelopmentMolecular Pharmacology
Publications per year
2013–2013
Characterization and preclinical development of LY2603618: a selective and potent Chk1 inhibitor
Constance King, Henry Diaz, Darlene Barnard et al. · Investigational New Drugs · 2013 · 109 citations
Molecular Pharmacology, Drug Target, Preclinical Development +8
Rows per page
1–1 of 1